2
|
Eid HM, Ouchfoun M, Saleem A, Guerrero-Analco JA, Walshe-Roussel B, Musallam L, Rapinski M, Cuerrier A, Martineau LC, Arnason JT, Haddad PS. A combination of (+)-catechin and (-)-epicatechin underlies the in vitro adipogenic action of Labrador tea (Rhododendron groenlandicum), an antidiabetic medicinal plant of the Eastern James Bay Cree pharmacopeia. JOURNAL OF ETHNOPHARMACOLOGY 2016; 178:251-257. [PMID: 26707751 DOI: 10.1016/j.jep.2015.12.021] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2015] [Revised: 12/05/2015] [Accepted: 12/17/2015] [Indexed: 06/05/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Rhododendron groenlandicum (Oeder) Kron & Judd (Labrador tea) was identified as an antidiabetic plant through an ethnobotanical study carried out with the close collaboration of Cree nations of northern Quebec in Canada. OBJECTIVES In a previous study the plant showed glitazone-like activity in a 3T3-L1 adipogenesis bioassay. The current study sought to identify the active compounds responsible for this potential antidiabetic activity using bioassay guided fractionation based upon an in vitro assay that measures the increase of triglycerides content in 3T3-L1 adipocyte. MATERIALS AND METHODS Isolation and identification of the crude extract's active constituents was carried out. The 80% ethanol extract was fractionated using silica gel column chromatography. Preparative HPLC was then used to isolate the constituents. The identity of the isolated compounds was confirmed by UV and mass spectrometry. RESULTS Nine chemically distinct fractions were obtained and the adipogenic activity was found in fraction 5 (RGE-5). Quercetins, (+)-catechin and (-)-epicatechin were detected and isolated from this fraction. While (+)-catechin and (-)-epicatechin stimulated adipogenesis (238±26% and 187±21% relative to vehicle control respectively) at concentrations equivalent to their concentrations in the active fraction RGE-5, none afforded biological activity similar to RGE-5 or the plant's crude extract when used alone. When cells were incubated with a mixture of the two compounds, the adipogenic activity was close to that of the crude extract (280.7±27.8 vs 311± 30%). CONCLUSION Results demonstrate that the mixture of (+)-catechin and (-)-epicatechin is responsible for the adipogenic activity of Labrador tea. This brings further evidence for the antidiabetic potential of R. groenlandicum and provides new opportunities to profile active principles in biological fluids or in traditional preparations.
Collapse
Affiliation(s)
- Hoda M Eid
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, Montréal, Québec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada; Department of Pharmacognosy, University of Beni-seuf, Beni-seuf, Egypt
| | - Meriem Ouchfoun
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, Montréal, Québec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada
| | - Ammar Saleem
- Centre for Research in Biotechnology and Biopharmaceuticals, Department of Biology, University of Ottawa, Ottawa, Ontario, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada
| | - Jose A Guerrero-Analco
- Centre for Research in Biotechnology and Biopharmaceuticals, Department of Biology, University of Ottawa, Ottawa, Ontario, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada; Advanced Molecular Studies Department-Institute of Ecology A.C., Xalapa, Veracruz, Mexico
| | - Brendan Walshe-Roussel
- Centre for Research in Biotechnology and Biopharmaceuticals, Department of Biology, University of Ottawa, Ottawa, Ontario, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada
| | - Lina Musallam
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, Montréal, Québec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada
| | - Michel Rapinski
- Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada; Institut de recherche en biologie végétale et Jardin Botanique de Montréal, Université de Montréal, Montréal, Quebec, Canada
| | - Alain Cuerrier
- Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada; Institut de recherche en biologie végétale et Jardin Botanique de Montréal, Université de Montréal, Montréal, Quebec, Canada
| | - Louis C Martineau
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, Montréal, Québec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada
| | - John T Arnason
- Centre for Research in Biotechnology and Biopharmaceuticals, Department of Biology, University of Ottawa, Ottawa, Ontario, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada
| | - Pierre S Haddad
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, Montréal, Québec, Canada; Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines and Montreal Diabetes Research Center, Montreal, Canada.
| |
Collapse
|
3
|
Ouchfoun M, Eid HM, Musallam L, Brault A, Li S, Vallerand D, Arnason JT, Haddad PS. Labrador tea (Rhododendron groenlandicum) attenuates insulin resistance in a diet-induced obesity mouse model. Eur J Nutr 2015; 55:941-54. [PMID: 25916863 DOI: 10.1007/s00394-015-0908-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2014] [Accepted: 04/17/2015] [Indexed: 12/18/2022]
Abstract
PURPOSE Using a diet-induced obesity (DIO) mouse model, we investigated the antidiabetic effect of Labrador tea [Rhododendron groenlandicum (Oeder) Kron and Judd], a beverage and medicinal tea used by the Cree Nations of northern Quebec. METHODS C57BL6 mice were divided into five groups and given standard chow (~4 % of lipids) or high-fat diet (~35 % of lipids) for 8 weeks until they became obese and insulin resistant. Treatment began by adding the plant extract at three doses (125, 250 and 500 mg/kg) to the high-fat diet for another 8 weeks. At the end of the study, insulin-sensitive tissues (liver, skeletal muscle, adipose tissue) were collected to investigate the plant's molecular mechanisms. RESULTS Labrador tea significantly reduced blood glucose (13 %), the response to an oral glucose tolerance test (18.2 %) and plasma insulin (65 %) while preventing hepatic steatosis (42 % reduction in hepatic triglyceride levels) in DIO mice. It stimulated insulin-dependent Akt pathway (55 %) and increased the expression of GLUT4 (53 %) in skeletal muscle. In the liver, Labrador tea stimulated the insulin-dependent Akt and the insulin-independent AMP-activated protein kinase pathways. The improvement in hepatic steatosis observed in DIO-treated mice was associated with a reduction in inflammation (through the IKK α/β) and a decrease in the hepatic content of SREBP-1 (39 %). CONCLUSIONS Labrador tea exerts potential antidiabetic action by improving insulin sensitivity and mitigating high-fat diet-induced obesity and hyperglycemia. They validate the safety and efficacy of this plant, a promising candidate for culturally relevant complementary treatment in Cree diabetics.
Collapse
Affiliation(s)
- Meriem Ouchfoun
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada.,Montreal Diabetes Research Center, Montréal, QC, Canada
| | - Hoda M Eid
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada.,Montreal Diabetes Research Center, Montréal, QC, Canada.,Department of Pharmacognosy, University of Beni-seuf, Beni-Seuf, Egypt
| | - Lina Musallam
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada.,Montreal Diabetes Research Center, Montréal, QC, Canada
| | - Antoine Brault
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada.,Montreal Diabetes Research Center, Montréal, QC, Canada
| | - Shilin Li
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada.,Montreal Diabetes Research Center, Montréal, QC, Canada
| | - Diane Vallerand
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada.,Montreal Diabetes Research Center, Montréal, QC, Canada
| | - John T Arnason
- Centre for Research in Biotechnology and Biopharmaceuticals, Department of Biology, University of Ottawa, Ottawa, ON, Canada.,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada.,Montreal Diabetes Research Center, Montréal, QC, Canada
| | - Pierre S Haddad
- Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada. .,Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montréal, QC, Canada. .,Montreal Diabetes Research Center, Montréal, QC, Canada.
| |
Collapse
|
8
|
Harbilas D, Martineau LC, Harris CS, Adeyiwola-Spoor DC, Saleem A, Lambert J, Caves D, Johns T, Prentki M, Cuerrier A, Arnason JT, Bennett SA, Haddad PS. Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part II. Can J Physiol Pharmacol 2009; 87:479-92. [DOI: 10.1139/y09-029] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Among the Cree of northern Quebec, the disproportionately high rate of diabetic complications is largely due to the cultural inadequacy of modern therapies for type 2 diabetes. To establish culturally adapted antidiabetic treatments, our team identified several candidate plant species used by the Cree to treat symptoms of diabetes. An initial study focused on 8 species and revealed that most possess significant in vitro antidiabetic activity. The purpose of the present study was to assess a further 9 species identified through the ethnobotanical survey. Crude plant extracts were screened for (i) potentiation of basal and insulin-stimulated glucose uptake by skeletal muscle cells (C2C12) and adipocytes (3T3-L1); (ii) potentiation of glucose-stimulated insulin secretion by pancreatic β cells (βTC); (iii) potentiation of adipogenesis in 3T3-L1 cells; (iv) protection against glucose toxicity and glucose deprivation in PC12-AC neuronal precursor cells; and (v) diphenylpicrylhydrazyl (DPPH) oxygen free radical scavenging. Four species potentiated basal glucose uptake in muscle cells or adipocytes, one species being as potent as metformin. Adipogenesis was accelerated by 4 species with a potency roughly half that of rosiglitazone. Five species protected PC12-AC cells against glucose toxicity and 4 protected against glucose deprivation. Five species exhibited antioxidant activity comparable to ascorbic acid. However, no species increased insulin secretion. The present study revealed that Gaultheria hispidula , Rhododendron tomentosum , and Vaccinium vitis-idaea exhibit a promising profile of antidiabetic potential and are good candidates for more in-depth evaluation.
Collapse
Affiliation(s)
- Despina Harbilas
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Louis C. Martineau
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Cory S. Harris
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Danielle C.A. Adeyiwola-Spoor
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Ammar Saleem
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Jennifer Lambert
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Dayna Caves
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Timothy Johns
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Marc Prentki
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Alain Cuerrier
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - John T. Arnason
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Steffany A.L. Bennett
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| | - Pierre S. Haddad
- Department of Pharmacology, Université de Montréal, P.O. Box 6128, Centre-ville Station, Montréal, QC H3C 3J7, Canada
- Nutraceuticals and Functional Foods Institute, Université Laval, Québec, QC G1K 7P4, Canada
- Montreal Diabetes Research Center, Centre de recherche du Centre hospitalier de l’Université de Montréal, 2901 Rachel East, Montréal, QC H1W 4A4, Canada
- Department of Biology and Center for Research in Biopharmaceuticals and Biotechnology, University of Ottawa, Ottawa, ON K1N 6N5, Canada
- Neural Regeneration Laboratory, Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada
| |
Collapse
|